Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis

INTRODUCTION: Antifibrinolytic agents are commonly used during cardiac surgery to minimize bleeding. Because of safety concerns, aprotinin was withdrawn from the market in 2007. Since then, tranexamic acid (TXA) has become the antifibrinolytic treatment of choice in many heart centers. The safety pr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sander, Michael, Spies, Claudia D, Martiny, Viktoria, Rosenthal, Christoph, Wernecke, Klaus-Dieter, von Heymann, Christian
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2010
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2945131/
https://ncbi.nlm.nih.gov/pubmed/20682059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc9216
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi